| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8285847 | Parkinsonism & Related Disorders | 2016 | 7 Pages |
Abstract
Researchers should consider the positive placebo response when they design clinical trials in advanced PD patients with motor fluctuations and severe motor symptoms. Baseline daily levodopa dose may be the independent predictor in studies that enrolled fluctuating patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Chae Won Shin, Seokyung Hahn, Byung-Joo Park, Jong-Min Kim, Eun Ok Park, Beomseok Jeon,